These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3100752)

  • 21. Genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase and their implications for therapy of leukemias.
    Hirschhorn R; Ratech H
    Curr Top Hematol; 1983; 4():1-35. PubMed ID: 6413135
    [No Abstract]   [Full Text] [Related]  

  • 22. Defining serum requirements of culture media for use in studies of physiological effects of various genetic diseases.
    Willis RC; Seegmiller JE
    Monogr Hum Genet; 1978; 10():92-5. PubMed ID: 102927
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunodeficiency secondary to adenosine deaminase deficiency and purine nucleoside phosphorylation deficiency.
    Carson DA; Carrera CJ
    Semin Hematol; 1990 Jul; 27(3):260-9. PubMed ID: 2115692
    [No Abstract]   [Full Text] [Related]  

  • 24. Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Grunebaum E; Cohen A; Roifman CM
    Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):630-8. PubMed ID: 24113229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hereditary anomalies of purine metabolism. Current biochemical aspects].
    Perignon JL; Cartier P
    Arch Fr Pediatr; 1980 Oct; 37(8):487-90. PubMed ID: 6255885
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary immunodeficiencies: development and trends].
    Stoop JW; Zegers BJ
    Ned Tijdschr Geneeskd; 1986 Sep; 130(36):1592-5. PubMed ID: 3093903
    [No Abstract]   [Full Text] [Related]  

  • 27. NAD synthesis in human erythrocytes: study of adenylyl transferase activities in patients bearing purine enzyme disorders.
    Sestini S; Pescaglini M; Magagnoli C; Jacomelli G; Rocchigiani M; Simmonds HA
    Adv Exp Med Biol; 1991; 309B():319-22. PubMed ID: 1664184
    [No Abstract]   [Full Text] [Related]  

  • 28. Adenosine deaminase (ADA) and other enzyme abnormalities in immune deficiency states.
    Goldblum RM; Schmalstieg FC; Nelson JA; Mills GC
    Birth Defects Orig Artic Ser; 1978; 14(6A):73-84. PubMed ID: 215243
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic defects in human purine and pyrimidine metabolism.
    Boss GR; Seegmiller JE
    Annu Rev Genet; 1982; 16():297-328. PubMed ID: 6297375
    [No Abstract]   [Full Text] [Related]  

  • 30. [Animal models for abnormal purine metabolism].
    Morisaki T
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():482-6. PubMed ID: 12629770
    [No Abstract]   [Full Text] [Related]  

  • 31. Enzyme defects in purine metabolism and immunodeficiencies.
    Ito K
    Nihon Ketsueki Gakkai Zasshi; 1985 Dec; 48(8):1764-71. PubMed ID: 3939170
    [No Abstract]   [Full Text] [Related]  

  • 32. Researchers seek guidance on "preproposal" for in utero gene therapy.
    Jenks S
    J Natl Cancer Inst; 1998 Oct; 90(20):1507. PubMed ID: 9790541
    [No Abstract]   [Full Text] [Related]  

  • 33. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 34. Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.
    Seegmiller JE
    Ann Rheum Dis; 1980 Apr; 39(2):103-17. PubMed ID: 6247984
    [No Abstract]   [Full Text] [Related]  

  • 35. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 36. Differences among immunosuppressive agents.
    Hitchings GH
    Ann Rheum Dis; 1982; 41 Suppl 1(Suppl 1):9-11. PubMed ID: 6802083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme defects and immune dysfunction.
    Rosen FS
    Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined familial adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Shanon A; Levin S; Holtzman F; Brock-Sinai F; Abu-Said A
    Arch Dis Child; 1988 Aug; 63(8):931-4. PubMed ID: 3137899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADA and PNP deficiencies: how it all began.
    Giblett ER
    Ann N Y Acad Sci; 1985; 451():1-8. PubMed ID: 3935025
    [No Abstract]   [Full Text] [Related]  

  • 40. [PNP (purine nucleoside phosphorylase) deficiency].
    Taniguchi A
    Nihon Rinsho; 2003 Jan; 61 Suppl 1():372-6. PubMed ID: 12629750
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.